After finishing at $4.28 in the prior trading day, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) closed at $4.12, down -3.74%. On the day, 762407 shares were traded.
Ratios:
Our goal is to gain a better understanding of VNDA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.61 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.09. For the most recent quarter (mrq), Quick Ratio is recorded 4.92 and its Current Ratio is at 4.94. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on February 25, 2022, Downgraded its rating to Hold and sets its target price to $12 from $24 previously.
On May 12, 2021, BofA Securities started tracking the stock assigning a Buy rating and target price of $22.
Citigroup Downgraded its Buy to Neutral on January 14, 2021, while the target price for the stock was maintained at $14.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 05 ’24 when Polymeropoulos Mihael Hristos sold 24,288 shares for $4.13 per share. The transaction valued at 100,273 led to the insider holds 1,871,730 shares of the business.
Wijkstrom Joakim sold 9,229 shares of VNDA for $38,830 on Mar 05 ’24. The SVP, Chief Marketing Officer now owns 129,789 shares after completing the transaction at $4.21 per share. On Mar 05 ’24, another insider, Moran Kevin Patrick, who serves as the SVP, CFO & Treasurer of the company, sold 8,902 shares for $4.20 each. As a result, the insider received 37,411 and left with 231,014 shares of the company.
Valuation Measures:
As of this moment, Vanda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 94.28. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.61. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.23 while its Price-to-Book (P/B) ratio in mrq is 0.44.
Stock Price History:
Over the past 52 weeks, VNDA has reached a high of $7.00, while it has fallen to a 52-week low of $3.30.
Shares Statistics:
A total of 57.53M shares are outstanding, with a floating share count of 54.51M. Insiders hold about 5.26% of the company’s shares, while institutions hold 88.94% stake in the company.
Earnings Estimates
Its stock is currently analyzed by NVIDIA Corporation different market analysts. The consensus estimate for the next quarter is $0.00, with high estimates of $4.12 and low estimates of $0.00.
EPS for the following year is $Currency, with Stocks analysts recommending between $Stocks and $Currency.
